Post-discharge thrombosis and bleeding in medical patients: A novel risk score derived from ubiquitous biomarkers.
Scott C WollerScott M StevensMasarret FaziliJames F LloydEmily L WilsonGregory L SnowJoseph R BledsoeBenjamin D HornePublished in: Research and practice in thrombosis and haemostasis (2021)
Risk scores derived from components of routine labs ubiquitous in clinical care identify patients that are at risk for 90-day postdischarge HA-VTE and major bleeding. This may identify a subset of patients with high HA-VTE risk and low HA-MB risk who may benefit from EDT.